NEW YORK--(BUSINESS WIRE)--Feb. 24, 2006--Xenomics, Inc. (OTCBB:XNOM) (FWB:XE7), a developer of next-generation medical DNA technologies, has announced the appointment of Company co-founder L. David Tomei, Ph.D., as new CEO. Dr. Tomei will remain in his post as co-Chairman. He replaces former CEO V. Randy White, Ph.D., who has left the Company to pursue other interests.
